Dose-Dependent Inhibition by Nitric Oxide and Pathophysiological Implications |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
The epithelium of the paranasal sinuses produces nitric oxide
(NO), which probably plays a major role in the nonspecific defense of these cavities through its bacteriostatic and cilia motility stimulation properties. Abundant eosinophils of nasal polyps potentially generate superoxide anion (O2
·), but NO and O2
· inactivate reciprocally. The purpose of the present work was to evaluate
the relationship between NO concentrations and nasal polyp production of O2
·. Polyp fragments from 24 patients were studied
using histological examination and lucigenin-enhanced chemiluminescence (to assess O2
· production). The effect of various concentrations of exogenous NO on chemiluminescent signals was assessed. Basal and phorbol ester-stimulated O2
· production varied
largely among patients, but both were highly related to eosinophilic infiltration. A slow releasing NO donor DETA NONOate
(DETA/NO NOC-18) dose dependently inhibited lucigenin-enhanced chemiluminescence from phorbol ester-stimulated polyp
fragments, with an EC50 of 1.5 mM. The NO concentration in normal maxillary sinus was estimated about 10 ppm (i.e., 0.5 µM in
aqueous phase) (Lundberg, et al. Nature Med 1995;1:370). Calculations revealed that the DETA NONOate 0.75 mM and 1.5 mM generate steady-state concentrations of NO of 0.5 µM and 2.5 µM,
respectively. In conclusion, the NO concentration present in paranasal sinuses appears to partially suppress (approximately 20-40%)
O2
· production from polyp eosinophils. Conversely, phagocytic-derived O2
· could contribute to decrease sinus NO concentration,
further altering this natural local defense. Together, these events
could participate in chronic inflammation and contribute to the
pathophysiology of nasal polyps.
| |
INTRODUCTION |
|---|
|
|
|---|
Nitric oxide (NO), a free radical gas previously considered
merely an atmospheric pollutant, is now recognized to be one
of the key mediators in many physiological and pathological
processes. NO is generated from arginine by a family of enzymes, the NO synthases, and acts as an autocrine and paracrine messenger (1). NO also plays a major role in nonspecific host defense due to its cytotoxicity toward tumor cells
and microorganisms. Inducible NO synthase (type II NO synthase) can be expressed after induction by proinflammatory cytokines or by bacterial lipopolysaccharide in many cell types (4). Thus, NO appears as a second line of defense against hard to kill pathogens in most mammalian tissues (4). The first line
of nonspecific host defense is the NADPH-oxidase of the phagocytic cells (monocyte-macrophage and polymorphonuclears),
which, upon activation, generate large amounts of superoxide
anion (O2
·) and derived reactive oxygen species (ROS, as hydrogen peroxide and hydroxyl radical) (5, 6).
However, this schematic view probably does not apply to all sites of the organism. The epithelia of the respiratory tract, bronchial (7) as well as paranasal sinuses (8), constitutively express the inducible NO synthase. As a consequence of the low air renewal in paranasal sinuses, very high concentrations of NO gas (5-20 parts per million [ppm]) have been measured in these cavities (8). Thus, NO could play a critical role in the physiology and pathology of the upper respiratory tract, because in addition to its role in nonspecific host defense (9), NO also stimulates ciliary motility (10). In the paranasal sinuses, NO appears to represent the first line of host defense, contributing to the sterility of these cavities (11). Inflammation of the sinus (i.e., sinusitis) induces the recruitement of phagocytic cells, which, in this particular case, represent a second line of defense (11). Thus, the strategy for host defense in the paranasal sinuses appears to be the reverse of that encountered in other cavities (such as the pulmonary alveola and peritoneal cavity) where resident macrophages are constitutively present to kill pathogens, whereas basal levels of NO are very low (12).
Because NO and O2
· both contain an unpaired electron,
they rapidly react together, leading to their reciprocal inactivation and eventually to peroxynitrite (ONOO
) (13, 14).
Peroxynitrite can, in turn, elicit protein tyrosine nitration, although other mechanisms, such as oxidation of nitrites by myeloperoxidase, can also elicit similar protein alterations (15).
The in vivo interaction between NO and O2
·, as well as the
consequences for host defense and cell toxicity, are hard to
predict for the following reasons: (1) in vivo concentrations of
NO cannot be easily determined with the technologies currently available, and the estimates in the literature vary widely
according to the authors, (2) the generation of O2
· is even
more difficult to determine, due to the very short half-life of
this ROS. Moreover, the validity of the most sensitive and commonly employed technique, lucigenin-enhanced chemiluminescence, has recently been questioned (16), and (3) the
very rapid interaction between NO and O2
· further complicates the assessment of each radical species (13, 14).
In the present study, we first applied electron spin resonance (ESR) spectroscopy using DMPO as spin trap, ferricytochrome c reduction, and lucigenin-enhanced chemiluminescence to assess the O2
· production of a macrophage cell line
RAW 264.7 and validate the latter technique. We also compared the effect of three NO donors on ESR and chemiluminescent signals. Fragments of nasal polyps from patients who
underwent surgery for nasal polyposis were then studied by
histological examination and lucigenin-enhanced chemiluminescence. The effect of various concentrations of an NO donor, DETA NONOate, on chemiluminescent signals from nasal polyps fragments was therefore investigated, and the NO
concentrations generated by DETA NONOate were calculated and compared with those reported in maxillary paranasal sinuses. The final goal of this work was to determine to
what extent the concentration of NO present in paranasal sinuses inactivates the O2
· production by phagocytes.
| |
METHODS |
|---|
|
|
|---|
Cell Culture and Materials
A mouse macrophage cell line (RAW 264.7; American Type Culture Collection, Rockville, MD) was cultured in Dulbecco's modified Eagle medium with 10% heat-inactivated fetal calf serum (GIBCO) supplemented with gentamycin (0.1 mg/ml) and amphotericin B (125 ng/ml) in a 5% CO2-containing atmosphere. RAW 264.7 were used when cells approached confluency (100,000/cm2) in the flasks or in 96 microwells.
Except when specified, all reagents were purchased from Sigma (St.
Louis, MO): superoxide dismutase (SOD, ref. S-2515; phorbol 12-myristate
13-acetate (PMA), identical to 12-O-tetradecanoylphorbol 13-acetate
[TPA]), catalase (ref. C-40), 5,5-dimethyl-1 pyrroline-N-oxide (DMPO),
diethylenetriaminepentaacetic acid (DTPA, ref. D-751), and activated
charcoal. DETA/NO NOC-18 and S-nitroso-N-acetyl-D,L-penicillamine (SNAP) were purchased from Alexis Biochemicals (San Diego, CA). DMPO was purified before use by treatment with activated charcoal for 15 min as reported in the literature (19), passed through a membrane filter (0.2 µm; Sartorius, Göttingen, Germany), aliquoted, protected from light and stored frozen at
20° C.
Patients with Nasal Polyposis
The procedures employed in this study were reviewed and approved by the local Ethics Committee (Comité consultatif de protection des personnes). The study was performed in 24 patients with nasal polyposis. The diagnosis of patients with nasal polyposis was based on the endoscopic observation of nasal polyps. Patients characteristics were mean age 46 ± 12 yr and sex ratio 16 males-8 females. Clinical symptoms were assessed the day of the NO measurement. The presence of symptoms (nasal obstruction, rhinorrhoea, and sneezing) the day of the NO measurement was noted, and the intensity (0, 1, 2 or 3) of each symptom was evaluated. The symptom scores were nasal obstruction 2.91 ± 0.29, rhinorrhea 1.09 ± 0.73, and sneezing 0.7 ± 0.7.
All patients underwent surgery for nasal polyposis, and the nasal polyps were removed surgically and stored at 4° C in Dulbecco's modified Eagle medium supplemented with gentamycin (0.1 mg/ml) and amphotericin B (125 ng/ml) for less than 1 h before being processed in the laboratory. The nasal polyps were then cut with a razor blade into fragments weighing 10 mg on average.
A nasal polyp from each patient was cut into two large fragments, one for histological examination, the other being segmented, depending on its size, into 15 to 25 fragments of approximately 10 mg.
Assessment of O2
· Production
ESR measurements. RAW 264.7 were cultured in a 25-cm2 flask, washed with phosphate-buffered saline (PBS), and then incubated with a mix containing 150 mM DMPO, 1 g/L glucose, 0.2 g/L CaCl2, 0.0059 g/L DTPA, 0.15 g/L NaCl, and 0.37 g/L KCl in sodium phosphate buffer (2.35 g/L NaH2PO4/7.61 g/L Na2HPO4, pH 7.4) containing phorbol myristate acetate (PMA) 1 µM for 10 min. The entire procedure was performed at 37° C. The supernatant was then transferred to a flat quartz cell that was inserted in a TM 110 Bruker cavity. ESR spectra were recorded at room temperature with an ER 200 D Bruker spectrometer by starting a 3 min scan 5 min after the end of the incubation with the cells. The ESR spectrometer operated at 9.66 GHz with high frequency at 100 kHz, modulation amplitude 1 G, time constant 0.5 s, microwave power 10 mW, field: midrange at 3,500 G, and scan range 20 G/min. The intensity of the ESR signal was calculated by adding the height of the four peaks, and expressed in arbitrary units as previously described (20). In some experiments, 5 min after the addition of a NO donor, RAW 264.7 were stimulated with 1 µM PMA.
SOD inhibitable reduction of cytochrome c. O2
· production was
measured as the SOD inhibitable reduction of cytochrome c (21). RAW 264.7 (400,000 cells/well) were preincubated with RPMI for 15 min at 37° C, washed once with RPMI, and incubated with 1 ml RPMI
containing 1 mg/ml cytochrome c with or without SOD (200 IU/ml) in
humidified air on a shaking table. Cytochrome c reduction was determined at zero time to obtain basal values and after the indicated time,
the absorbance of the medium was read spectrophotometrically at
550 nm against a distilled water blank. Reduction of cytochrome c in
the presence of SOD was subtracted from the values without SOD:
the proportion of superoxide specific reduction of cytochrome c (i.e.,
SOD inhibitable) was between 30 and 50% depending on the experiments. In some experiments, RAW 264.7 were stimulated with 1 µM
PMA, 5 min after the addition of an NO donor.
Lucigenin-enhanced chemiluminescence. RAW 264.7 were cultured in 96-microwells. The production of reactive oxygen intermediates was measured using the chemiluminogenic probe lucigenin. The
medium was removed from the wells and the cells washed twice with
Krebs-Henseleit bicarbonate (KHB) (composition [mM]: NaCl 99.0, KCl 4.69, CaCl2 1.87, MgSO4 1.2, NaHCO3 25, K2HPO4 1.03, Na-HEPES 20, D-glucose 11.1) with 1 µM PMA for 10 min, and lucigenin
(250 µM final) was then added. The 96 microwells were thermostatically (37° C) controlled, and chemiluminescence was triggered with 1 µm
PMA through an automatic injector (200 µl of final volume in each
well), continuously monitored for 30 min and expressed in relative
light unit/min. An average O2
· production was calculated from that
of the different fragments, and this value was then used in correlation
with histological scores. In some experiments, RAW 264.7 were stimulated with 1 µm PMA 5 min after the addition of an NO donor.
Calculation of the Steady State Concentration of NO Generated by DETA/NO NOC-18
Decomposition of NONOates was monitored spectrophotometrically, at 37° C, in 0.1 M phosphate buffer, pH 7.4. For simulation of NO production, it was considered that NONOates release two equivalents of NO and that NO auto-oxidizes in aqueous solutions according to the following equations (22):
|
|
[O2] being constant and equal to 220 µM.
The second integration method of Runge-Kutta was used (23). A small integration step was used to simulate the reactions at the initial times; as a rule, the initial integration step size was of the order of one-hundredth of the reaction time of the fastest reaction. The calculations were performed using the spreadsheet Excel 98 (Microsoft Office).
Histological Examination
The abundance of inflammatory cells was estimated using a semiquantitative score: 1 for a low number of inflammatory cells, 2 for a moderate infiltration by inflammatory cells on the chorion surface, and 3 for an intense infiltration by inflammatory cells on the chorion surface. The percentage of eosinophils in the inflammatory cells was also estimated using a semiquantitative score: 1 for < 10% of eosinophils, 2 for 10-50% of eosinophils, and 3 for > 50% of eosinophils. Finally, fibrosis was semiquantified as follows: 1 for chorion's edema, 2 for normal chorion, and 3 for constituted sclerosis of the chorion.
Statistical Analysis
The data were expressed as mean of triplicate values. The relation between the variables was calculated using Pearson's rank-correlation coefficients. p values of < 0.05 were considered significant. Analysis was performed with the SPSS program.
| |
RESULTS |
|---|
|
|
|---|
Validation of O2
· Measurements
ESR signals detected using DMPO as spin trap. After 15 min
incubation of DMPO with RAW 264.7 stimulated by 1 µm
PMA, a typical ESR signal was obtained resulting from the
DMPO-OH adduct (Figure 1A). This adduct could result
from hydroxyl radical trapping by DMPO in the extracellular
medium. However, it is well known that the DMPO-OOH adduct, resulting from the trapping of O2
·, rapidly decomposes
into a more stable adduct: DMPO-OH (24). To identify the
ROS released by the RAW 264.7 and initially trapped by
DMPO, the effects of SOD and catalase were tested as previously reported (25, 26). When SOD 30 U/ml was coincubated,
the ESR signal was completely suppressed (not shown). In
contrast, neither denatured SOD (15 min boiling) nor catalase
(2,000 U/ml) affected the ESR signal (not shown). Together,
these results demonstrate that the ESR adduct DMPO-OH
detected in the supernatant of RAW 264.7 originated from the
trapping of extracellular O2
·. The ESR signal given by unstimulated (basal) cells was about 10-fold the baseline (Figure
1). As shown in Figure 2, three NO donors (sodium nitroprusside, DETA/NO NOC-18, and SNAP) dose dependently inhibited the amplitude of the ESR adduct DMPO-OH from
RAW 264.7.
|
|
Cytochrome c reduction technique. RAW 264.7 stimulated
by 1 µm PMA induced an immediate SOD-inhibitable cytochrome c reduction, which was suppressed if SOD was previously boiled for 15 min. Catalase (2,000 U/ml) had no effect
(not shown). These results demonstrate that SOD-inhibitable
cytochrome c reduction signal elicited by PMA-stimulated
RAW 264.7 is mainly due to extracellular O2
·.
Lucigenin-elicited chemiluminescent signals from macrophage cell line. RAW 264.7 stimulated by 1 µm PMA induced
an immediate lucigenin-elicited chemiluminescent signal. Representative tracings are shown in Figure 1B. SOD 100 U/ml
and diphenyleneiodonium (DPI) 100 µM inhibited
90% of
the lucigenin-enhanced chemiluminescent signal. In contrast,
coincubation with denatured SOD (15 min boiling) or with
catalase (2,000 U/ml) did not affect the morphology or the
amplitude of the chemiluminescent signal (not shown). Altogether, these results demonstrate that the lucigenin-enhanced
chemiluminescent signal elicited by PMA-stimulated RAW
264.7 is mainly due to extracellular O2
·. As shown in Figure
2, the three NO donors dose dependently inhibited the amplitude of the lucigenin-enhanced chemiluminescent signal from
RAW 264.7.
Histological Examination of Nasal Polyps and Relation to Lucigenin-elicited Chemiluminescent Signals
Eight fragments of each polyp were used to study the reproducibility of lucigenin-elicited chemiluminescence. For a given polyp, some variations were found for both basal and TPA-stimulated lucigenin-elicited chemiluminescence (Figures 3A
and 3B). A mean value was calculated for each polyp and used
for subsequent correlations with histology. Large variations in
both basal and TPA-stimulated lucigenin-elicited chemiluminescence were also found between patients, and these are ordered from lowest to highest O2
· producer in Figures 3A and
3B. Histological examination revealed the presence of various
degrees of inflammation as well as fibrosis (Figure 4).
|
|
Basal lucigenin-elicited chemiluminescence (calculated mean
from the eight fragments) was significantly correlated with
eosinophils abundance (r = 0.37, p < 0.05), fibrosis abundance (r =
0.3, p < 0.05) but not with cell abundance (r =
0.01, p = 0.8) (not shown). Similarly, TPA-stimulated lucigenin-elicited chemiluminescence was significantly correlated with eosinophils abundance (r = 0.67, p < 0.01) (Figure
5A), fibrosis abundance (r =
0.43, p < 0.05) (Figure 5B), but
not with cell abundance (r = 0.27, p = 0.18) (Figure 5C).
|
Characterization of the Lucigenin-elicited Chemiluminescent Signals from Nasal Polyps
Polyp fragments stimulated by 1 µM PMA induced an immediate lucigenin-elicited chemiluminescent signal. Representative tracings are shown in Figure 1C. SOD 100 U/ml and DPI
100 µM inhibited = 90% of the lucigenin-enhanced chemiluminescent signal (Figure 6). In contrast, coincubation with
denatured SOD (15 min boiling, data not shown), with catalase (2,000 U/ml), or with Nw-nitro-L-arginine methyl ester
(L-NAME) (100 µM) did not affect the morphology or the
amplitude of the chemiluminescent signal. Altogether, these
results demonstrate that the lucigenin-enhanced chemiluminescent signal elicited by PMA-stimulated polyp fragment is
mainly due to extracellular O2
·, a result analogous to that obtained with RAW 264.7.
|
Effect of a DETA NONOate on the O2
·-elicited
Signals from Fragments of Nasal Polyps
Various concentrations of DETA NONOate were added 5 min before the addition of 1 µm PMA. As shown in Figure 7, DETA/ NO NOC-18 dose dependently inhibited the lucigenin-enhanced chemiluminescent signal with an EC50 of approximately 1.5 mM.
|
Calculation of the Steady-State Concentration of NO Generated by DETA/NO NOC-18
Calculations revealed that 0.75 mM and 1.5 mM of the DETA NONOate generate steady-state NO concentrations of 0.5 µM and 2.5 µM, respectively.
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of the present study are as follows: (1) Electron spin resonance (ESR) spectroscopy using DMPO as spin trap, ferricytochrome c reduction, and lucigenin-enhanced
chemiluminescence can apparently detect the O2
· production
from a macrophage cell line RAW 264.7. Three different NO
donors dose dependently inhibited these ESR and lucigenin-enhanced chemiluminescent signals. (2) The basal and stimulated O2
· production in nasal polyps largely varied among patients, and were correlated to eosinophilic abundance. (3) A slow
releasing NO donor, DETA NONOate, dose dependently
inhibited lucigenin-enhanced chemiluminescence from TPA-stimulated polyp fragments. (4) The NO concentrations generated by DETA/NO NOC-18 were calculated, and those inhibiting lucigenin-enhanced chemiluminescence were found to
be within the range of those in the maxillary paranasal sinuses.
The first goal of the present study was to validate a technique allowing the evaluation of O2
· generation in cells and
ex vivo tissues. Indeed, several factors account for the difficulty in assessing the generation of O2
· in biological systems.
O2
· has a very short half-life due to its spontaneous dismutation, which is accelerated by SOD, and also to its rapid reaction with other radical species such as NO (6, 14). In addition,
two of the three major techniques used to assess the production of O2
· have recently been questioned. The simplest and
easiest method for the detection of O2
· is the reduction of
ferricytochome c. However, Thomson and coworkers recently
reported the oxidation of cytochrome c by peroxynitrite (27).
These authors pointed out that O2
· formation as measured
with the cytochrome c reduction technique can be underestimated when NO is simultaneously generated at a comparable
rates. This is why we did not determine this technique to study
the effect of NO donors on O2
· production. Lucigenin luminescence has been widely used to assess the production of
O2
·. However, the reliability of this technique was also recently questioned (16). Far fewer studies have used ESR
spectroscopy because this technique requires an expensive
tool and is time consuming compared with the two previous ones.
In the absence of NO, we found that ESR spectroscopy using DMPO as spin trap, ferricytochrome c reduction, and lucigenin-enhanced chemiluminescence were apparently correlated and quite suitable for assessing the high O2
· production
from a macrophage cell line RAW 264.7. In addition, three
NO donors (sodium nitroprusside, DETA/NO NOC-18, and
SNAP) dose dependently inhibited the amplitude of the ESR
and of the lucigenin-enhanced chemiluminescence signals
from RAW 264.7.
Thus, lucigenin-enhanced chemiluminescence, which is more
sensitive than ESR, was subsequently applied to assess O2
·
production in fragments of nasal polyps. Large variations of lucigenin-elicited chemiluminescence were found among patients, together with heterogeneous inflammatory cell and
eosinophil abundance. Interestingly, both basal and TPA-stimulated lucigenin-elicited chemiluminescence were significantly correlated with eosinophils abundance, but not with cell
abundance. This correlation is probably the consequence of
the high O2
· production of eosinophils, this type of phagocytic cells being the most rich in NADPH oxidase (28).
NO influences O2
· availability by at least two mechanisms.
First, because NO and O2
· both contains an unpaired electron, both species inactivate each other. Second, NO prevents
the activation of NADPH oxidase by inhibiting its assembly
process (29). In the present study, the NO donor was added
before stimulating the phagocytic cells with TPA to mimic the
in vivo conditions (where both mechanisms are acting in concert). Concentrations of DETA/NO NOC-18 applied before
TPA stimulation of phagocytic NADPH oxidase dose dependently inhibited the TPA-stimulated lucigenin-elicited chemiluminescence from nasal polyp fragments, with an EC50 of approximately 1.5 mM. At equilibrium, NO concentrations of
10-20 ppm were measured in normal maxillary sinuses (8) and
are equivalent to a concentration of 0.45-0.90 µM in the aqueous phase (30). Concentrations of 0.75 mM and 1.5 mM
DETA/NO NOC-18 were calculated to generate steady-state
NO concentrations of 0.5 µM (10 ppm) and 2.5 µM (50 ppm),
respectively. Thus, NO concentrations present in maxillary sinuses partially inhibit (approximately 20-40%) the TPA-stimulated lucigenin-elicited chemiluminescence, that is, phagocytic O2
· production. The high concentration reached in the
paranasal sinus cavities is probably due to the fact that the
cavity is almost closed, and thus, the NO concentration can attain values close to the µM range. In contrast, in our experiments, the endogenous production of NO by the fragments of
nasal polyp rapidly diffused into the air. Under these in vitro
conditions, the concentration of NO due to endogenous production did not reach a level high enough to inhibit endogenous superoxide production, as demonstrated by the lack of
effect of the NO synthase inhibitor L-NAME (Figure 6).
It has been shown that the NO concentrations found in normal sinuses are sufficient to inhibit the growth of several bacteria (9, 31). This reinforces the idea that under normal conditions, NO represents the first line of defense of the paranasal sinuses. Indirect evidence is supported by the dramatic decrease of nasal NO concentration in patients with Kartagener's syndrome (referred to as an "immobile cilia syndrome" and characterized by situs inversus, sinusitis, and bronchiectasis) (32, 33). However, the sensitivity of the various pathogens to NO, ROS, peroxynitrite, and the synergism and/or antagonism between these two mechanisms of defense require further study (31), and understanding of their respective roles in the pathophysiology of paranasal sinuses probably requires refined modeling. Finally, myeloperoxidase of eosinophils represents an alternative and potentially prominent mechanism of protein nitration (15). This important question about the link between these mechanisms and the pathobiology of the paranasal sinuses also deserves specific treatment.
In conclusion, it appears that the paranasal sinuses are an
unusual anatomic site where NO accounts for the first line of nonspecific host defense, which could interfere and counteract the second line of defense constituted by the phagocytic
cells.The NO concentrations found in paranasal sinuses appear to be within the critical range to inactivate the production of O2
· by phagocytes. In vivo, this scheme could be complicated by additional events such as (1) allergic rhinitis
increases in nasal NO concentration (33, 34), which can be
normalized upon glucocorticoid treatment (35); (2) the potential generation of peroxynitrite, as the respective amounts of
NO and O2
· reach stoichiometry near 1:1, a condition favorable for the generation of peroxynitrite (14); and (3) the inhibition of apoptosis of certain phagocytic cells such as eosinophils by NO (36). All three mechanisms could contribute to
the chronicity of the inflammatory process and thus to the
pathophysiology of polyposis. All these events should be analyzed in future studies.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to J.-F. Arnal, Service d'exploration fonctionnelle respiratoire, CHU Rangueil, 31403 Toulouse Cedex, France. E-mail: arnal{at}rangueil.inserm.fr
(Received in original form February 29, 2000 and in revised form June 28, 2000).
Acknowledgments:
This work was supported in part by the Délégation à la Recherche Clinique des
Hôpitaux de Toulouse (97-51-H) and by INSERM.
| |
References |
|---|
|
|
|---|
1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018.
2. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 1989; 3: 31-36 [Abstract].
3.
Moncada S,
Higgs A.
The L-arginine-nitric oxide pathway.
N Engl J Med
1993;
329:
2002-2012
4. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-2423 [Medline].
5. Chanock S, El Benna J, Smith R, Babior B. The respiratory burst oxidase. J Biol Chem 1994;269:24519-24522.
6.
Fridovich I.
Superoxide anion radical, superoxide dismutases, and related matters.
J Biol Chem
1997;
272:
18515-18517
7.
Guo F,
De Raeve H,
Rice T,
Stuehr D,
Thunnissen F,
Erzurum S.
Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal airway epithelium in vivo.
Proc Natl Acad Sci USA
1995;
92:
7809-7813
8. Lundberg J, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Änggård A, Hökfelt J, Lundberg JM, Alving K. High nitric oxide production in human paranasal sinuses. Nature Med 1995; 1: 370-373 [Medline].
9.
Mancinelli R,
McKay C.
Effects of nitric oxide and nitrogen dioxide on
bacterial growth.
Appl Environ Microbiol
1983;
46:
198-202
10. Jain B, Rubinstein I, Robbins R, Leise K, Sisson J. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993; 191: 83-88 [Medline].
11. Kaliner M, Osguthorpe D, Fireman P, Anon J, Georgitis J, Davis M, Nacero R, Kennedy D. Sinusitis: bench to bedside. J Allergy Clin Immunol 1997; 99: S829-S848 [Medline].
12. Thébaud B, Arnal J, Mercier J, Dinh-Xuan A. Inhaled and exhaled nitric oxide. Cell Mol Life Sci 1999; 55: 1103-1112 . [Medline]
13. Rubbo H, Darley-Usmar V, Freeman B. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996; 9: 809-820 [Medline].
14.
Beckman JS,
Koppenol WH.
Nitric oxide, superoxide, and peroxynitrate: the good, the bad, and the ugly.
Am J Physiol
1996;
271:
C1424-C1437
15.
Van der Vliet A,
Eiserich J,
Shigenaga M,
Cross C.
Reactive nitrogen
species and tyrosine nitration in the respiratory tract.
Am J Respir Crit
Care Med
1999;
160:
1-9
16. Liochev SI, Fridovich I. Lucigenin (Bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys 1997; 337: 115-120 [Medline].
17. Liochev SI, Fridovich I. Lucigenin as mediator of superoxide production: revisited. Free Rad Biol Med 1998; 25: 926-928 [Medline].
18. Vasquez-Vivar J, Hogg N, Pritchard KA Jr,, Martasek P, Kalyanaraman B. Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study. FEBS Letters 1997; 403: 127-130 [Medline].
19. Buettner GR, Oberley LW. Consideration in the spin trapping of superoxide and hydroxyl radicals in aqueous systems using 5,5-dimethyl-1-pyrroline-1-oxide. Biochem Biophys Res Commun 1978; 83: 69-74 [Medline].
20. Souchard J, Barbacanne M, Margeat E, Maret A, Nepveu F, Arnal J. EPR detection of extracellular superoxide anion released by cultured endothelial cells. Free Rad Res 1998; 29: 441-449 [Medline].
21. Steinbrecher UP. Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochim Biophys Acta 1988; 959: 20-30 [Medline].
22.
Kharitonov V,
Sundquist A,
Sharma V.
Kinetics of nitric oxide autoxidation in aqueous solution.
J Biol Chem
1994;
269:
5881-5883
23. Stieffel E. Differential equations. In: An introduction to numerical mathematics. New York: Academic Press; 1966. p. 139-217.
24. Halliwell B, Gutteridge JMC. Detection of free radicals and other reactive species: trapping and fingerprinting. DMPO and PBN. In: Halliwell B, Gutteridge JMC, editors. Free radicals in biology and medicine, 3rd ed. Oxford: Clarendon Press; 1999. p. 357-358.
25.
Mason RP, Morehouse KM. Spin trapping
the ideal method for measuring oxygen radical formation? In: Rice-Evans C, Halliwell B, editors. Free radicals: methodology and concepts. London: Richelieu;
1994. p. 157-168.
26.
Finkelstein E,
Rosen GM,
Rauckman EJ,
Paxton J.
Spin trapping of superoxide.
Mol Pharmacol
1979;
16:
676-685
27. Thomson L, Trujillo M, Telleri R, Radi R. Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys 1995; 319: 491-497 [Medline].
28.
Someya A,
Nishijima K,
Nunoi H,
Irie S,
Nagaoka I.
Study of the superoxide-producing enzyme of eosinophils and neutrophils
comparison
of the NADPH oxidase components.
Arch Biochem Biophys
1997;
345:
207-213
[Medline].
29. Clancy R, Leszczynska-Piziak J, Abramson S. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116-1121 .
30. Petit J, Nicaise M, Lepoivre M, Guissani A, Lemaire G. Protection by glutathione against the antiproliferative effects of nitric oxide. Biochem Pharmacol 1996; 52: 205-212 [Medline].
31. Kaplan S, Lacanster J Jr,, Basford R, Simmons R. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun 1996; 64: 69-76 [Abstract].
32. Lundberg J, Weitzberg E, Nordvall S, Kuylenstierna R, Lundberg J, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J 1994; 7: 1501-1504 [Abstract].
33. Arnal J-F, Flores P, Rami J, Murris-Espin M, Bremont F, Pasto M, Aguilla I, Serrano E, Didier A. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999; 13: 307-312 [Abstract].
34. Arnal JF, Didier A, Rami J, M'Rini C, Charlet JP, Serrano E, Bescombes JP. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997; 27: 358-362 [Medline].
35. Kharitonov S, Rajakulasingam K, O'Connor B, Durham S, Barnes P. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997; 99: 58-64 [Medline].
36.
Hebestreit H,
Dibbert B,
Balatti I,
Braun D,
Shapowal A,
Blase K,
Simon HV.
Disruption of Fas receptor signaling by nitric oxide in eosinophils.
J Exp Med
1998;
187:
415-425
This article has been cited by other articles:
![]() |
B. Degano, M. Genestal, E. Serrano, J. Rami, and J.-F. Arnal Effect of Treatment on Maxillary Sinus and Nasal Nitric Oxide Concentrations in Patients With Nosocomial Maxillary Sinusitis Chest, September 1, 2005; 128(3): 1699 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim and J. A. Hanley The Role of Woodstoves in the Etiology of Nasal Polyposis Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 682 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |